Literature DB >> 12899727

Successful use of gemtuzumab ozogamicin in a child with relapsed CD33-positive acute lymphoblastic leukaemia.

Melanie Cotter, Sean Rooney, Aengus O'Marcaigh, Owen P Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12899727     DOI： 10.1046/j.1365-2141.2003.04485.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  3 in total

1.  Combination of chemotherapy and gemtuzumab ozogamicin in adult Philadelphia positive acute lymphoblastic leukemia patient harboring CD33 expression.

Authors:  Patrice Chevallier; Beatrice Mahe; Richard Garand; Pascaline Talmant; Jean-Luc Harousseau; Jacques Delaunay
Journal:  Int J Hematol       Date:  2008-08-01       Impact factor: 2.490

Review 2.  Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.

Authors:  Keith J August; Aru Narendran; Kathleen A Neville
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

Review 3.  Antibody therapy for pediatric leukemia.

Authors:  Aditi Vedi; David S Ziegler
Journal:  Front Oncol       Date:  2014-04-21       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.